Effects of riluzole on rat cortical neurones: An in vitro electrophysiological study

British Journal of Pharmacology

Volumn 120, Issue 2, 1997, Pages 225-230

  Siniscalchi, Antonio ^b   Bonci, Antonello ^b   Mercuri, Nicola B ^a   Bernardi, Giorgio ^b  

^a IRCCS   (Italy)

^b NONE

Author keywords

Brain slices; Epilepsy; Field potentials; Neuroprotection; Repetitive firing; Sodium and calcium spikes

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM ION; GLUTAMIC ACID; RILUZOLE; SODIUM ION; TETRODOTOXIN; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; EPILEPSY; EVOKED CORTICAL RESPONSE; FRONTAL CORTEX; INTRACELLULAR RECORDING; MALE; MEMBRANE STEADY POTENTIAL; NERVE CELL; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; CALCIUM; CEREBRAL CORTEX; GLUTAMIC ACID; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RILUZOLE; THIAZOLES;

EID: 0031036733     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700905     Document Type: Article

References (47)

1. BENAVIDES, J., CAMELIN, J.C., MITRANI, N., FLAMAND, F., UZAN, A., LEGRAND, J.J., GUEREMY, C. & LE FUR, G. (1985). 2-Amino-6-trifluoromethoxy benzothiazole. A possible antagonist of excitatory aminoacid transmission II. Neuropharmacology, 24, 1085-1092.
2. BENSIMON, G., LACLOMBEZ, L. & MEININGER, V. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group (see comment). N. Engl. J. Med., 330, 585-591.
3. BENOIT, E. & ESCANDE, D. (1991). Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflugers. Arch., 419, 603-609.
4. BRADFORD, H.F. (1995). Glutamate, Gaba and epilepsy. Prog. Neurobiol., 47, 411-511.
5. BROWN, A.M., SCHWINDT, P.C. & CRILL, W.E. (1993). Voltage-dependence and activation kinetics of pharmacologically defined components of the high-threshold calcium current in rat neocortical neurons. J. Neurophysiol., 20, 757-771.
6. CALABRESI, P., SINISCALCHI, A., PISANI, A, STEFANI, A., MERCURI, N.B. & BERNARDI, G. (1996). A field potential analysis on the effects of lamotrigine, GP 47779 and felbamate in neocortical slices. Neurology, 41, 557-562.
7. CAPEK, R. & ESPLIN, B. (1994). Effects of lidocaine on hippocampal pyramidal cells: depression of repetitive firing. NeuroReport, 5, 681-684.
8. CHERMAY, A., BARBEITO, L., GODEHEAU, G. & GLOWINSKI, J. (1992). Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci. Lett., 147, 209-212.
9. CHEUNG, H., KAMP, D. & HARRIS, E. (1992). An in vitro investigation of the action of lamotrigine on neuronal-activated sodium channels. Epilepsy Res., 13, 107-112.
10. CONNORS, B.W. & GUTNICK, M.J. (1990). Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci., 13, 99-104.
11. CONNORS, B.W., GUTNICK, M.J. & PRINCE, D.A. (1982). Electrophysiological properties of neocortical neurons in vitro. J. Neurophysiol., 48, 1302-1320.
12. DEBONO, M.W., LE GUERN, J., CANTON, T., DOBLE, A. & PRADIER, L. (1993). Inhibition of riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur. J. Pharmacol., 235, 283-289.
13. 3H]-aspartate release from cultured cerebellar granule cells. Neurosci. Lett., 140, 251-254.
14. DREJER, J., HONORE, T., MEIER, E. & SCHOUSBOE, A. (1986). Pharmacologically distinct glutamate receptors on cerebellar granule cells. Life Sci., 38, 2077-2085.
15. FRANZ, P., GALVAN, M. & CONSTANTI, A. (1986). Calcium-dependent action potentials and associated inward currents in guinea-pig neocortical neurons in vitro. Brain Res., 366, 262-271.
16. GREENAMYRE, J.T. & YOUNG, A.B. (1989). Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging, 10, 593-602.
17. HABLITZ, J.J. & SUTOR, B. (1990). Excitatory postsynaptic potentials in rat neocortical neurons in vitro. II Effects of a quinoxalinedione non-NMDA receptor antagonist. J. Neurophysiol., 64, 1282-1290.
18. HUBERT, J.P., DELUMEAU, J.C., GLOWINSKI, J., PREMONT, J. & DOBLE, A. (1994). Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action. Br. J. Pharmacol., 113, 261-267.
19. 3H]-aspartate release from cultured cerebellar granule cells. Neurosci. Lett., 26, 345-350.
20. HWA, G.G.C. & AVOLI, M. (1992). Excitatory postsynaptic potentials recorded from regular-spiking cells in layers II/III of rat sensimotor cortex. J. Neurophysiol., 67, 728-737.
21. MARTIN, D., THOMPSON, M.A. & NADLER, J.V. (1993). The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur. J. Pharmacol., 250, 473-476.
22. MAULGORIS, C., BARDOT, F., DANIEL, M., PELLIS, F., RATAUD, J., UZAN, A., BLANCHARD, J.C. & LADURON, P.M. (1989). Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J. Neurosci., 9, 3720-3727.
23. MATSUKI, N., QAUNDT, F.N., TEN ELICK, R.E. & YEH, J.Z. (1984). Characterization of the block of the sodium channels by phenytoin in mouse neuroblastoma cells. J. Pharmacol. Exp. Ther., 228, 523-530.
24. MCLEAN, M.J. & MACDONALD, R.L. (1986). Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther., 238, 727-737.
25. MCNAMARA, J.O. (1994). Cellular and molecular basis of epilepsy. J. Neurosci., 14, 3413-3425.
26. MELDRUM, B.S. (1990). Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev., 2, 27-57.
27. MELDRUM, B.S. & GARTHWAITE, J. (1990). Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci., 11, 379-386.
28. MIZOULE, J., MELDRUM, B., MAZAIDIER, M., CRHOUCHER, M., OLLAT, C., UZAN, A., LEGRAND, J.J., GUEREMY, C. & LE FUR, G. (1985). 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission: I. Neuropharmacology, 24, 767-773.
29. PISANI, A., STEFANI, A., SINISCALCHI, A., MERCURI, N.B., BERNARDI, G. & CALABRESI, P. (1995). Electrophysiology actions of felbamate on rat striatal neurones. Br. J. Pharmacol., 116, 2053-2061.
30. PRATT, J., RATAUD, J., BARDOT, F., ROUX, M., BLANCHARD, J.-C., LADURON, P.M. & STUTZMANN, J.M. (1992). Neuroprotective actions of riluzole in rodent models of global and focal ischaemia. Neurosci. Lett., 140, 225-230.
31. ROWLAND, L.P. (1994). Amyotrophic lateral sclerosis. Curr. Opin. Neurol., 7, 310-315.
32. ROTHSTEIN, J.D. & KUNCL, R.W. (1995). Neuroprotective strategies in a model of chronic glutamate-medicated motor neuron toxicity. J. Neurochem., 65, 643-651.
33. SAYER, R.J., SCHWINDT, P.C. & CRILL, W.E (1990). High-and low-threshold calcium currents in neurons acutely isolated from rat sensorimotor cortex. Neurosci. Lett., 120, 175-178.
34. SCHACHTER, S.C. (1995). Review of the mechanisms of action of antiepileptic drugs. CNS Drugs, 4, 469-477.
35. SIESJO, B.K. & BENGTSSON, F. (1989). Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischaemia, hypoglycemia, and spreading depression: a unifying hypothesis J. Cereb. Blood Flow Metab., 9, 127-140.
36. SINDOU, P., COURATIER, P., ESCLAIRE, F., YARDIN, C., BOUSSEAU, A. & HUGON, J. (1994). Prevention of HIV coat protein (gp 120) toxicity in cortical cell cultures by riluzole. J. Neurol. Sci., 126, 133-137.
37. STAFSTROM, C.E., SCHWINDT, P.C., CHUBB, M.C. & CRILL, W.E. (1985). Properties of persistent sodium conductance and calcium conductance of layer V neurons from cat sensorimotor cortex in vitro. J. Neurophysiol., 53, 153-170.
38. STEFANI, A., PISANI, A., DE MURTAS, M., MERCURI, N.B., MARCIANI, M.G. & CALABRESI, P. (1995). Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. Epilepsia, 336, 997-1002.
39. STUTZMANN, J.M., BHOME, G.A., GANDOLFO, G., GOTTESMANN, C., LAFFORGUE, J., BLANCHARD, J.-C., LADURON, P.M. & LAZDUNSKI, M. (1991). Riluzole prevents hyperexcitability produced by mast cell degranulating peptide and dendrotoxin I in the rat. Eur. J. Pharmacol., 193, 223-229.
40. STUTZMANN, J.M., PRATT, J., BOURAD, T. & GROSS, C. (1996). The effect of riluzole on post-traumatic spinal cord injury in the rat. Neuro Report, 7, 387-392.
41. TAKAHASHI, T. & MOMIYAMA, A. (1993). Different types of calcium channels mediate central synaptic transmission. Nature, 366, 156-158.
42. + channels as targets for neuroprotective drugs. Trends. Pharmacol. Sci., 16, 309-316.
43. UMEMIYA, M. & BERGER, A.J. (1995). Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurones. Br. J. Pharmacol., 116, 3227-3230.
44. VAN DEN BERG, R.J., KOK, P. & VOSKUYL, R.A. (1993). Valproate and sodium currents in cultured hippocampal neurons. Exp. Brain. Res., 93, 279-287.
45. WALKER, M.C. & SANDER, J.W. (1994). Developments in anti-epileptic drug therapy. Curr. Op. Neurol., 7, 131-139.
46. WAMIL, A.W. & MCLEAN, M.J. (1994). Limitation by gabapentin of high-frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res., 17, 1-11.
47. YAARI, Y., SELTZER, M. & PINCUS, J. (1986). Phenytoin: mechanism of its anticonvulsant action. Ann. Neurol., 20, 171-184.